Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...
LightPath Technologies, Inc. ( LPTH) Q1 2026 Earnings Call November 11, 2025 5:00 PM EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback